We are live on
!
Find out more
Emergent Biosolutions
EBS
EBS
181 hedge funds and large institutions have $1.2B invested in Emergent Biosolutions in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 78 increasing their positions, 56 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
39% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 56
38% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 16
16% more capital invested
Capital invested by funds: $1.03B → $1.2B (+$167M)
3% more funds holding
Funds holding: 176 → 181 (+5)
0.5% less ownership
Funds ownership: 87.44% → 86.95% (-0.5%)
64% less call options, than puts
Call options by funds: $1.94M | Put options by funds: $5.37M
Holders
181
Holders Change
+5
Holders Change %
+2.84%
% of All Funds
4.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
78
Reduced
56
Closed
16
Calls
$1.94M
Puts
$5.37M
Net Calls
-$3.43M
Net Calls Change
-$3.23M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$19.5M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$8.98M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.69M |
| 4 |
BlackRock
New York
|
+$4.65M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$4.28M |
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.43M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.81M |
| 3 |
Millennium Management
New York
|
-$5.47M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.47M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.04M |
